US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT07221357 Phase 2, Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Che...
Condition
Untreated, Unresectable, or Metastatic Colorectal Cancer
Enrollment
990 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04640584 N/A
Recruiting
C-Brace Prospective Registry
Condition
Pareses
Enrollment
250 pts
Location
United States, Australia, Germany
Sponsor
Otto Bock Healthcare Products
View Trial →
NCT07766005 Phase 2
Recruiting
A Study of SPY072 in Adults With Moderate to Severe Hidradenitis Suppurativa (Th...
Condition
Hidradenitis Suppurativa (HS)
Enrollment
150 pts
Location
United States, Canada
Sponsor
Spyre Therapeutics, Inc.
View Trial →
NCT05866081 N/A
Recruiting
Stent Omission After Ureteroscopy and Lithotripsy in the Michigan Urological Sur...
Condition
Stone, Kidney
Enrollment
792 pts
Location
United States
Sponsor
University of Michigan
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT03328611 N/A
Recruiting
MCJR Joint Replacement Clinical Outcomes Database
Condition
Joint Replacement
Enrollment
2,000 pts
Location
United States
Sponsor
Midwest Center for Joint Repla
View Trial →
NCT05557877 Phase 2
Recruiting
Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
Condition
Breast Carcinoma
Enrollment
60 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Argentina, Brazil
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT05564377 Phase 2
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally A...
Condition
Advanced Malignant Solid Neoplasm
Enrollment
2,900 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06121011 N/A
Recruiting
A Global Prospective Observational Registry of Patients With Pompe Disease
Condition
Pompe Disease
Enrollment
500 pts
Location
United States, Austria, Belgium
Sponsor
Amicus Therapeutics
View Trial →
NCT06087029 N/A
Recruiting
IMPRoving Outcomes in Vascular DisEase - Aortic Dissection
Condition
Type B Aortic Dissection
Enrollment
1,100 pts
Location
United States, Canada
Sponsor
Duke University
View Trial →
NCT04207437 N/A
Recruiting
Daily Hand-Held Vibration Therapy
Condition
Neuropathy
Enrollment
16 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT03797495 N/A
Recruiting
Study of Individuals Affected With Hypoplasminogenemia
Condition
Plasminogen Deficiency
Enrollment
100 pts
Location
United States, Argentina, Australia
Sponsor
Indiana Hemophilia &Thrombosis
View Trial →
NCT07533331 N/A
Recruiting
Testing Conversational Agents as a Digital Companion
Condition
Autism
Enrollment
38 pts
Location
United States
Sponsor
Friendi.fi Corporation
View Trial →
NCT05446272 N/A
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Condition
Extubation Failure
Enrollment
478 pts
Location
United States, Canada
Sponsor
University of Pennsylvania
View Trial →
NCT06095505 Phase 2
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
Condition
Small Cell Lung Cancer
Enrollment
120 pts
Location
United States
Sponsor
Puma Biotechnology, Inc.
View Trial →
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
View Trial →
NCT07536269 Phase 2
Recruiting
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in P...
Condition
Congenital Adrenal Hyperplasia
Enrollment
20 pts
Location
United States
Sponsor
Neurocrine Switzerland GmbH
View Trial →
NCT07586618 Phase 1
Recruiting
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Har...
Condition
Lymphoblastic Lymphoma
Enrollment
24 pts
Location
United States
Sponsor
Allterum Therapeutics, Inc
View Trial →
NCT06270589 N/A
Recruiting
Acute Effects of High-intensity Interval Training With Mindfulness-based Recover...
Condition
Healthy Volunteers
Enrollment
60 pts
Location
United States
Sponsor
Purdue University
View Trial →
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
View Trial →
NCT07585968 N/A
Recruiting
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System f...
Condition
Ventricular Tachycardia
Enrollment
260 pts
Location
United States
Sponsor
Medtronic Cardiac Ablation Sol
View Trial →
NCT03945162 Phase 2
Recruiting
Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Mus...
Condition
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG
Enrollment
90 pts
Location
United States, Canada
Sponsor
Theralase® Technologies Inc.
View Trial →
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
View Trial →
Page 1 of 8 — 178 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology